Document is current

Any future updates will be listed below

Correction to: Improved quality of life in cystic fibrosis patients observed up to 36 months after starting Elexacaftor/Tezacaftor/Ivacaftor treatment

Crossref DOI link: https://doi.org/10.1186/s41687-025-00976-0

Published Online: 2026-02-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark